Global Short Bowel Syndrome Drugs Market Research Report 2025(Status and Outlook)
Report Overview
The market for Short Bowel Syndrome (SBS) drugs focuses on therapies designed to manage malabsorption and nutritional deficiencies in patients who have undergone significant intestinal resection, leaving them with insufficient functional gut length. SBS is a rare but severe condition that often requires lifelong medical intervention, including specialized pharmacotherapies such as glucagon-like peptide-2 (GLP-2) analogs (e.g., teduglutide), growth hormone treatments, and parenteral nutrition support. The market is driven by the increasing prevalence of conditions leading to intestinal resection (e.g., Crohn?s disease, ischemic bowel disease, and congenital defects), advancements in biologic therapies, and rising awareness of rare disease treatments. Key players include Takeda Pharmaceutical (marketing teduglutide as Gattex/Revestive) and niche biotech firms developing novel approaches like intestinal rehabilitation therapies. However, challenges persist, including high treatment costs, limited patient pools due to the rarity of SBS, and reimbursement hurdles in certain regions. Growth opportunities lie in expanding orphan drug designations, improving patient access in emerging markets, and developing next-generation therapies targeting gut adaptation and microbiome modulation.
This report provides a deep insight into the global Short Bowel Syndrome Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Short Bowel Syndrome Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Short Bowel Syndrome Drugs market in any manner.
Global Short Bowel Syndrome Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Emmaus Medical
Merck
Takeda
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
GLyPharma Therapeutic
Sancilio Pharmaceuticals
Zealand Pharma
Market Segmentation (by Type)
Oral Short Bowel Syndrome Drugs
Tablet Short Bowel Syndrome Drugs
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Short Bowel Syndrome Drugs Market
Overview of the regional outlook of the Short Bowel Syndrome Drugs Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Short Bowel Syndrome Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Short Bowel Syndrome Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The market for Short Bowel Syndrome (SBS) drugs focuses on therapies designed to manage malabsorption and nutritional deficiencies in patients who have undergone significant intestinal resection, leaving them with insufficient functional gut length. SBS is a rare but severe condition that often requires lifelong medical intervention, including specialized pharmacotherapies such as glucagon-like peptide-2 (GLP-2) analogs (e.g., teduglutide), growth hormone treatments, and parenteral nutrition support. The market is driven by the increasing prevalence of conditions leading to intestinal resection (e.g., Crohn?s disease, ischemic bowel disease, and congenital defects), advancements in biologic therapies, and rising awareness of rare disease treatments. Key players include Takeda Pharmaceutical (marketing teduglutide as Gattex/Revestive) and niche biotech firms developing novel approaches like intestinal rehabilitation therapies. However, challenges persist, including high treatment costs, limited patient pools due to the rarity of SBS, and reimbursement hurdles in certain regions. Growth opportunities lie in expanding orphan drug designations, improving patient access in emerging markets, and developing next-generation therapies targeting gut adaptation and microbiome modulation.
This report provides a deep insight into the global Short Bowel Syndrome Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Short Bowel Syndrome Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Short Bowel Syndrome Drugs market in any manner.
Global Short Bowel Syndrome Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Emmaus Medical
Merck
Takeda
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
GLyPharma Therapeutic
Sancilio Pharmaceuticals
Zealand Pharma
Market Segmentation (by Type)
Oral Short Bowel Syndrome Drugs
Tablet Short Bowel Syndrome Drugs
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Short Bowel Syndrome Drugs Market
Overview of the regional outlook of the Short Bowel Syndrome Drugs Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Short Bowel Syndrome Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Short Bowel Syndrome Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Short Bowel Syndrome Drugs
1.2 Key Market Segments
1.2.1 Short Bowel Syndrome Drugs Segment by Type
1.2.2 Short Bowel Syndrome Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SHORT BOWEL SYNDROME DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Short Bowel Syndrome Drugs Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Short Bowel Syndrome Drugs Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SHORT BOWEL SYNDROME DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Short Bowel Syndrome Drugs Product Life Cycle
3.3 Global Short Bowel Syndrome Drugs Sales by Manufacturers (2020-2025)
3.4 Global Short Bowel Syndrome Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Short Bowel Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Short Bowel Syndrome Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Short Bowel Syndrome Drugs Market Competitive Situation and Trends
3.8.1 Short Bowel Syndrome Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest Short Bowel Syndrome Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 SHORT BOWEL SYNDROME DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Short Bowel Syndrome Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SHORT BOWEL SYNDROME DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Short Bowel Syndrome Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Short Bowel Syndrome Drugs Market
5.7 ESG Ratings of Leading Companies
6 SHORT BOWEL SYNDROME DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Short Bowel Syndrome Drugs Sales Market Share by Type (2020-2025)
6.3 Global Short Bowel Syndrome Drugs Market Size Market Share by Type (2020-2025)
6.4 Global Short Bowel Syndrome Drugs Price by Type (2020-2025)
7 SHORT BOWEL SYNDROME DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Short Bowel Syndrome Drugs Market Sales by Application (2020-2025)
7.3 Global Short Bowel Syndrome Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global Short Bowel Syndrome Drugs Sales Growth Rate by Application (2020-2025)
8 SHORT BOWEL SYNDROME DRUGS MARKET SALES BY REGION
8.1 Global Short Bowel Syndrome Drugs Sales by Region
8.1.1 Global Short Bowel Syndrome Drugs Sales by Region
8.1.2 Global Short Bowel Syndrome Drugs Sales Market Share by Region
8.2 Global Short Bowel Syndrome Drugs Market Size by Region
8.2.1 Global Short Bowel Syndrome Drugs Market Size by Region
8.2.2 Global Short Bowel Syndrome Drugs Market Size Market Share by Region
8.3 North America
8.3.1 North America Short Bowel Syndrome Drugs Sales by Country
8.3.2 North America Short Bowel Syndrome Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Short Bowel Syndrome Drugs Sales by Country
8.4.2 Europe Short Bowel Syndrome Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Short Bowel Syndrome Drugs Sales by Region
8.5.2 Asia Pacific Short Bowel Syndrome Drugs Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Short Bowel Syndrome Drugs Sales by Country
8.6.2 South America Short Bowel Syndrome Drugs Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Short Bowel Syndrome Drugs Sales by Region
8.7.2 Middle East and Africa Short Bowel Syndrome Drugs Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 SHORT BOWEL SYNDROME DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Short Bowel Syndrome Drugs by Region(2020-2025)
9.2 Global Short Bowel Syndrome Drugs Revenue Market Share by Region (2020-2025)
9.3 Global Short Bowel Syndrome Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Short Bowel Syndrome Drugs Production
9.4.1 North America Short Bowel Syndrome Drugs Production Growth Rate (2020-2025)
9.4.2 North America Short Bowel Syndrome Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Short Bowel Syndrome Drugs Production
9.5.1 Europe Short Bowel Syndrome Drugs Production Growth Rate (2020-2025)
9.5.2 Europe Short Bowel Syndrome Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Short Bowel Syndrome Drugs Production (2020-2025)
9.6.1 Japan Short Bowel Syndrome Drugs Production Growth Rate (2020-2025)
9.6.2 Japan Short Bowel Syndrome Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Short Bowel Syndrome Drugs Production (2020-2025)
9.7.1 China Short Bowel Syndrome Drugs Production Growth Rate (2020-2025)
9.7.2 China Short Bowel Syndrome Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Emmaus Medical
10.1.1 Emmaus Medical Basic Information
10.1.2 Emmaus Medical Short Bowel Syndrome Drugs Product Overview
10.1.3 Emmaus Medical Short Bowel Syndrome Drugs Product Market Performance
10.1.4 Emmaus Medical Business Overview
10.1.5 Emmaus Medical SWOT Analysis
10.1.6 Emmaus Medical Recent Developments
10.2 Merck
10.2.1 Merck Basic Information
10.2.2 Merck Short Bowel Syndrome Drugs Product Overview
10.2.3 Merck Short Bowel Syndrome Drugs Product Market Performance
10.2.4 Merck Business Overview
10.2.5 Merck SWOT Analysis
10.2.6 Merck Recent Developments
10.3 Takeda
10.3.1 Takeda Basic Information
10.3.2 Takeda Short Bowel Syndrome Drugs Product Overview
10.3.3 Takeda Short Bowel Syndrome Drugs Product Market Performance
10.3.4 Takeda Business Overview
10.3.5 Takeda SWOT Analysis
10.3.6 Takeda Recent Developments
10.4 Ardelyx
10.4.1 Ardelyx Basic Information
10.4.2 Ardelyx Short Bowel Syndrome Drugs Product Overview
10.4.3 Ardelyx Short Bowel Syndrome Drugs Product Market Performance
10.4.4 Ardelyx Business Overview
10.4.5 Ardelyx Recent Developments
10.5 Naia Pharmaceuticals
10.5.1 Naia Pharmaceuticals Basic Information
10.5.2 Naia Pharmaceuticals Short Bowel Syndrome Drugs Product Overview
10.5.3 Naia Pharmaceuticals Short Bowel Syndrome Drugs Product Market Performance
10.5.4 Naia Pharmaceuticals Business Overview
10.5.5 Naia Pharmaceuticals Recent Developments
10.6 Nutrinia
10.6.1 Nutrinia Basic Information
10.6.2 Nutrinia Short Bowel Syndrome Drugs Product Overview
10.6.3 Nutrinia Short Bowel Syndrome Drugs Product Market Performance
10.6.4 Nutrinia Business Overview
10.6.5 Nutrinia Recent Developments
10.7 OxThera
10.7.1 OxThera Basic Information
10.7.2 OxThera Short Bowel Syndrome Drugs Product Overview
10.7.3 OxThera Short Bowel Syndrome Drugs Product Market Performance
10.7.4 OxThera Business Overview
10.7.5 OxThera Recent Developments
10.8 GLyPharma Therapeutic
10.8.1 GLyPharma Therapeutic Basic Information
10.8.2 GLyPharma Therapeutic Short Bowel Syndrome Drugs Product Overview
10.8.3 GLyPharma Therapeutic Short Bowel Syndrome Drugs Product Market Performance
10.8.4 GLyPharma Therapeutic Business Overview
10.8.5 GLyPharma Therapeutic Recent Developments
10.9 Sancilio Pharmaceuticals
10.9.1 Sancilio Pharmaceuticals Basic Information
10.9.2 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Product Overview
10.9.3 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Product Market Performance
10.9.4 Sancilio Pharmaceuticals Business Overview
10.9.5 Sancilio Pharmaceuticals Recent Developments
10.10 Zealand Pharma
10.10.1 Zealand Pharma Basic Information
10.10.2 Zealand Pharma Short Bowel Syndrome Drugs Product Overview
10.10.3 Zealand Pharma Short Bowel Syndrome Drugs Product Market Performance
10.10.4 Zealand Pharma Business Overview
10.10.5 Zealand Pharma Recent Developments
11 SHORT BOWEL SYNDROME DRUGS MARKET FORECAST BY REGION
11.1 Global Short Bowel Syndrome Drugs Market Size Forecast
11.2 Global Short Bowel Syndrome Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Short Bowel Syndrome Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Short Bowel Syndrome Drugs Market Size Forecast by Region
11.2.4 South America Short Bowel Syndrome Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Short Bowel Syndrome Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Short Bowel Syndrome Drugs Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Short Bowel Syndrome Drugs by Type (2026-2033)
12.1.2 Global Short Bowel Syndrome Drugs Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Short Bowel Syndrome Drugs by Type (2026-2033)
12.2 Global Short Bowel Syndrome Drugs Market Forecast by Application (2026-2033)
12.2.1 Global Short Bowel Syndrome Drugs Sales (K Units) Forecast by Application
12.2.2 Global Short Bowel Syndrome Drugs Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Short Bowel Syndrome Drugs
1.2 Key Market Segments
1.2.1 Short Bowel Syndrome Drugs Segment by Type
1.2.2 Short Bowel Syndrome Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SHORT BOWEL SYNDROME DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Short Bowel Syndrome Drugs Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Short Bowel Syndrome Drugs Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SHORT BOWEL SYNDROME DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Short Bowel Syndrome Drugs Product Life Cycle
3.3 Global Short Bowel Syndrome Drugs Sales by Manufacturers (2020-2025)
3.4 Global Short Bowel Syndrome Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Short Bowel Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Short Bowel Syndrome Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Short Bowel Syndrome Drugs Market Competitive Situation and Trends
3.8.1 Short Bowel Syndrome Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest Short Bowel Syndrome Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 SHORT BOWEL SYNDROME DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Short Bowel Syndrome Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SHORT BOWEL SYNDROME DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Short Bowel Syndrome Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Short Bowel Syndrome Drugs Market
5.7 ESG Ratings of Leading Companies
6 SHORT BOWEL SYNDROME DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Short Bowel Syndrome Drugs Sales Market Share by Type (2020-2025)
6.3 Global Short Bowel Syndrome Drugs Market Size Market Share by Type (2020-2025)
6.4 Global Short Bowel Syndrome Drugs Price by Type (2020-2025)
7 SHORT BOWEL SYNDROME DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Short Bowel Syndrome Drugs Market Sales by Application (2020-2025)
7.3 Global Short Bowel Syndrome Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global Short Bowel Syndrome Drugs Sales Growth Rate by Application (2020-2025)
8 SHORT BOWEL SYNDROME DRUGS MARKET SALES BY REGION
8.1 Global Short Bowel Syndrome Drugs Sales by Region
8.1.1 Global Short Bowel Syndrome Drugs Sales by Region
8.1.2 Global Short Bowel Syndrome Drugs Sales Market Share by Region
8.2 Global Short Bowel Syndrome Drugs Market Size by Region
8.2.1 Global Short Bowel Syndrome Drugs Market Size by Region
8.2.2 Global Short Bowel Syndrome Drugs Market Size Market Share by Region
8.3 North America
8.3.1 North America Short Bowel Syndrome Drugs Sales by Country
8.3.2 North America Short Bowel Syndrome Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Short Bowel Syndrome Drugs Sales by Country
8.4.2 Europe Short Bowel Syndrome Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Short Bowel Syndrome Drugs Sales by Region
8.5.2 Asia Pacific Short Bowel Syndrome Drugs Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Short Bowel Syndrome Drugs Sales by Country
8.6.2 South America Short Bowel Syndrome Drugs Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Short Bowel Syndrome Drugs Sales by Region
8.7.2 Middle East and Africa Short Bowel Syndrome Drugs Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 SHORT BOWEL SYNDROME DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Short Bowel Syndrome Drugs by Region(2020-2025)
9.2 Global Short Bowel Syndrome Drugs Revenue Market Share by Region (2020-2025)
9.3 Global Short Bowel Syndrome Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Short Bowel Syndrome Drugs Production
9.4.1 North America Short Bowel Syndrome Drugs Production Growth Rate (2020-2025)
9.4.2 North America Short Bowel Syndrome Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Short Bowel Syndrome Drugs Production
9.5.1 Europe Short Bowel Syndrome Drugs Production Growth Rate (2020-2025)
9.5.2 Europe Short Bowel Syndrome Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Short Bowel Syndrome Drugs Production (2020-2025)
9.6.1 Japan Short Bowel Syndrome Drugs Production Growth Rate (2020-2025)
9.6.2 Japan Short Bowel Syndrome Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Short Bowel Syndrome Drugs Production (2020-2025)
9.7.1 China Short Bowel Syndrome Drugs Production Growth Rate (2020-2025)
9.7.2 China Short Bowel Syndrome Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Emmaus Medical
10.1.1 Emmaus Medical Basic Information
10.1.2 Emmaus Medical Short Bowel Syndrome Drugs Product Overview
10.1.3 Emmaus Medical Short Bowel Syndrome Drugs Product Market Performance
10.1.4 Emmaus Medical Business Overview
10.1.5 Emmaus Medical SWOT Analysis
10.1.6 Emmaus Medical Recent Developments
10.2 Merck
10.2.1 Merck Basic Information
10.2.2 Merck Short Bowel Syndrome Drugs Product Overview
10.2.3 Merck Short Bowel Syndrome Drugs Product Market Performance
10.2.4 Merck Business Overview
10.2.5 Merck SWOT Analysis
10.2.6 Merck Recent Developments
10.3 Takeda
10.3.1 Takeda Basic Information
10.3.2 Takeda Short Bowel Syndrome Drugs Product Overview
10.3.3 Takeda Short Bowel Syndrome Drugs Product Market Performance
10.3.4 Takeda Business Overview
10.3.5 Takeda SWOT Analysis
10.3.6 Takeda Recent Developments
10.4 Ardelyx
10.4.1 Ardelyx Basic Information
10.4.2 Ardelyx Short Bowel Syndrome Drugs Product Overview
10.4.3 Ardelyx Short Bowel Syndrome Drugs Product Market Performance
10.4.4 Ardelyx Business Overview
10.4.5 Ardelyx Recent Developments
10.5 Naia Pharmaceuticals
10.5.1 Naia Pharmaceuticals Basic Information
10.5.2 Naia Pharmaceuticals Short Bowel Syndrome Drugs Product Overview
10.5.3 Naia Pharmaceuticals Short Bowel Syndrome Drugs Product Market Performance
10.5.4 Naia Pharmaceuticals Business Overview
10.5.5 Naia Pharmaceuticals Recent Developments
10.6 Nutrinia
10.6.1 Nutrinia Basic Information
10.6.2 Nutrinia Short Bowel Syndrome Drugs Product Overview
10.6.3 Nutrinia Short Bowel Syndrome Drugs Product Market Performance
10.6.4 Nutrinia Business Overview
10.6.5 Nutrinia Recent Developments
10.7 OxThera
10.7.1 OxThera Basic Information
10.7.2 OxThera Short Bowel Syndrome Drugs Product Overview
10.7.3 OxThera Short Bowel Syndrome Drugs Product Market Performance
10.7.4 OxThera Business Overview
10.7.5 OxThera Recent Developments
10.8 GLyPharma Therapeutic
10.8.1 GLyPharma Therapeutic Basic Information
10.8.2 GLyPharma Therapeutic Short Bowel Syndrome Drugs Product Overview
10.8.3 GLyPharma Therapeutic Short Bowel Syndrome Drugs Product Market Performance
10.8.4 GLyPharma Therapeutic Business Overview
10.8.5 GLyPharma Therapeutic Recent Developments
10.9 Sancilio Pharmaceuticals
10.9.1 Sancilio Pharmaceuticals Basic Information
10.9.2 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Product Overview
10.9.3 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Product Market Performance
10.9.4 Sancilio Pharmaceuticals Business Overview
10.9.5 Sancilio Pharmaceuticals Recent Developments
10.10 Zealand Pharma
10.10.1 Zealand Pharma Basic Information
10.10.2 Zealand Pharma Short Bowel Syndrome Drugs Product Overview
10.10.3 Zealand Pharma Short Bowel Syndrome Drugs Product Market Performance
10.10.4 Zealand Pharma Business Overview
10.10.5 Zealand Pharma Recent Developments
11 SHORT BOWEL SYNDROME DRUGS MARKET FORECAST BY REGION
11.1 Global Short Bowel Syndrome Drugs Market Size Forecast
11.2 Global Short Bowel Syndrome Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Short Bowel Syndrome Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Short Bowel Syndrome Drugs Market Size Forecast by Region
11.2.4 South America Short Bowel Syndrome Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Short Bowel Syndrome Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Short Bowel Syndrome Drugs Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Short Bowel Syndrome Drugs by Type (2026-2033)
12.1.2 Global Short Bowel Syndrome Drugs Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Short Bowel Syndrome Drugs by Type (2026-2033)
12.2 Global Short Bowel Syndrome Drugs Market Forecast by Application (2026-2033)
12.2.1 Global Short Bowel Syndrome Drugs Sales (K Units) Forecast by Application
12.2.2 Global Short Bowel Syndrome Drugs Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Short Bowel Syndrome Drugs Market Size Comparison by Region (M USD)
Table 5. Global Short Bowel Syndrome Drugs Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Short Bowel Syndrome Drugs Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Short Bowel Syndrome Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Short Bowel Syndrome Drugs Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Bowel Syndrome Drugs as of 2024)
Table 10. Global Market Short Bowel Syndrome Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Short Bowel Syndrome Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Short Bowel Syndrome Drugs Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Short Bowel Syndrome Drugs Sales by Type (K Units)
Table 26. Global Short Bowel Syndrome Drugs Market Size by Type (M USD)
Table 27. Global Short Bowel Syndrome Drugs Sales (K Units) by Type (2020-2025)
Table 28. Global Short Bowel Syndrome Drugs Sales Market Share by Type (2020-2025)
Table 29. Global Short Bowel Syndrome Drugs Market Size (M USD) by Type (2020-2025)
Table 30. Global Short Bowel Syndrome Drugs Market Size Share by Type (2020-2025)
Table 31. Global Short Bowel Syndrome Drugs Price (USD/Unit) by Type (2020-2025)
Table 32. Global Short Bowel Syndrome Drugs Sales (K Units) by Application
Table 33. Global Short Bowel Syndrome Drugs Market Size by Application
Table 34. Global Short Bowel Syndrome Drugs Sales by Application (2020-2025) & (K Units)
Table 35. Global Short Bowel Syndrome Drugs Sales Market Share by Application (2020-2025)
Table 36. Global Short Bowel Syndrome Drugs Market Size by Application (2020-2025) & (M USD)
Table 37. Global Short Bowel Syndrome Drugs Market Share by Application (2020-2025)
Table 38. Global Short Bowel Syndrome Drugs Sales Growth Rate by Application (2020-2025)
Table 39. Global Short Bowel Syndrome Drugs Sales by Region (2020-2025) & (K Units)
Table 40. Global Short Bowel Syndrome Drugs Sales Market Share by Region (2020-2025)
Table 41. Global Short Bowel Syndrome Drugs Market Size by Region (2020-2025) & (M USD)
Table 42. Global Short Bowel Syndrome Drugs Market Size Market Share by Region (2020-2025)
Table 43. North America Short Bowel Syndrome Drugs Sales by Country (2020-2025) & (K Units)
Table 44. North America Short Bowel Syndrome Drugs Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Short Bowel Syndrome Drugs Sales by Country (2020-2025) & (K Units)
Table 46. Europe Short Bowel Syndrome Drugs Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Short Bowel Syndrome Drugs Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Short Bowel Syndrome Drugs Market Size by Region (2020-2025) & (M USD)
Table 49. South America Short Bowel Syndrome Drugs Sales by Country (2020-2025) & (K Units)
Table 50. South America Short Bowel Syndrome Drugs Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Short Bowel Syndrome Drugs Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Short Bowel Syndrome Drugs Market Size by Region (2020-2025) & (M USD)
Table 53. Global Short Bowel Syndrome Drugs Production (K Units) by Region(2020-2025)
Table 54. Global Short Bowel Syndrome Drugs Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Short Bowel Syndrome Drugs Revenue Market Share by Region (2020-2025)
Table 56. Global Short Bowel Syndrome Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Short Bowel Syndrome Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Short Bowel Syndrome Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Short Bowel Syndrome Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Short Bowel Syndrome Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Emmaus Medical Basic Information
Table 62. Emmaus Medical Short Bowel Syndrome Drugs Product Overview
Table 63. Emmaus Medical Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Emmaus Medical Business Overview
Table 65. Emmaus Medical SWOT Analysis
Table 66. Emmaus Medical Recent Developments
Table 67. Merck Basic Information
Table 68. Merck Short Bowel Syndrome Drugs Product Overview
Table 69. Merck Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Merck Business Overview
Table 71. Merck SWOT Analysis
Table 72. Merck Recent Developments
Table 73. Takeda Basic Information
Table 74. Takeda Short Bowel Syndrome Drugs Product Overview
Table 75. Takeda Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Takeda Business Overview
Table 77. Takeda SWOT Analysis
Table 78. Takeda Recent Developments
Table 79. Ardelyx Basic Information
Table 80. Ardelyx Short Bowel Syndrome Drugs Product Overview
Table 81. Ardelyx Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Ardelyx Business Overview
Table 83. Ardelyx Recent Developments
Table 84. Naia Pharmaceuticals Basic Information
Table 85. Naia Pharmaceuticals Short Bowel Syndrome Drugs Product Overview
Table 86. Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Naia Pharmaceuticals Business Overview
Table 88. Naia Pharmaceuticals Recent Developments
Table 89. Nutrinia Basic Information
Table 90. Nutrinia Short Bowel Syndrome Drugs Product Overview
Table 91. Nutrinia Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Nutrinia Business Overview
Table 93. Nutrinia Recent Developments
Table 94. OxThera Basic Information
Table 95. OxThera Short Bowel Syndrome Drugs Product Overview
Table 96. OxThera Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. OxThera Business Overview
Table 98. OxThera Recent Developments
Table 99. GLyPharma Therapeutic Basic Information
Table 100. GLyPharma Therapeutic Short Bowel Syndrome Drugs Product Overview
Table 101. GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. GLyPharma Therapeutic Business Overview
Table 103. GLyPharma Therapeutic Recent Developments
Table 104. Sancilio Pharmaceuticals Basic Information
Table 105. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Product Overview
Table 106. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Sancilio Pharmaceuticals Business Overview
Table 108. Sancilio Pharmaceuticals Recent Developments
Table 109. Zealand Pharma Basic Information
Table 110. Zealand Pharma Short Bowel Syndrome Drugs Product Overview
Table 111. Zealand Pharma Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Zealand Pharma Business Overview
Table 113. Zealand Pharma Recent Developments
Table 114. Global Short Bowel Syndrome Drugs Sales Forecast by Region (2026-2033) & (K Units)
Table 115. Global Short Bowel Syndrome Drugs Market Size Forecast by Region (2026-2033) & (M USD)
Table 116. North America Short Bowel Syndrome Drugs Sales Forecast by Country (2026-2033) & (K Units)
Table 117. North America Short Bowel Syndrome Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 118. Europe Short Bowel Syndrome Drugs Sales Forecast by Country (2026-2033) & (K Units)
Table 119. Europe Short Bowel Syndrome Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 120. Asia Pacific Short Bowel Syndrome Drugs Sales Forecast by Region (2026-2033) & (K Units)
Table 121. Asia Pacific Short Bowel Syndrome Drugs Market Size Forecast by Region (2026-2033) & (M USD)
Table 122. South America Short Bowel Syndrome Drugs Sales Forecast by Country (2026-2033) & (K Units)
Table 123. South America Short Bowel Syndrome Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Middle East and Africa Short Bowel Syndrome Drugs Sales Forecast by Country (2026-2033) & (Units)
Table 125. Middle East and Africa Short Bowel Syndrome Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 126. Global Short Bowel Syndrome Drugs Sales Forecast by Type (2026-2033) & (K Units)
Table 127. Global Short Bowel Syndrome Drugs Market Size Forecast by Type (2026-2033) & (M USD)
Table 128. Global Short Bowel Syndrome Drugs Price Forecast by Type (2026-2033) & (USD/Unit)
Table 129. Global Short Bowel Syndrome Drugs Sales (K Units) Forecast by Application (2026-2033)
Table 130. Global Short Bowel Syndrome Drugs Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Short Bowel Syndrome Drugs Market Size Comparison by Region (M USD)
Table 5. Global Short Bowel Syndrome Drugs Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Short Bowel Syndrome Drugs Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Short Bowel Syndrome Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Short Bowel Syndrome Drugs Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Bowel Syndrome Drugs as of 2024)
Table 10. Global Market Short Bowel Syndrome Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Short Bowel Syndrome Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Short Bowel Syndrome Drugs Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Short Bowel Syndrome Drugs Sales by Type (K Units)
Table 26. Global Short Bowel Syndrome Drugs Market Size by Type (M USD)
Table 27. Global Short Bowel Syndrome Drugs Sales (K Units) by Type (2020-2025)
Table 28. Global Short Bowel Syndrome Drugs Sales Market Share by Type (2020-2025)
Table 29. Global Short Bowel Syndrome Drugs Market Size (M USD) by Type (2020-2025)
Table 30. Global Short Bowel Syndrome Drugs Market Size Share by Type (2020-2025)
Table 31. Global Short Bowel Syndrome Drugs Price (USD/Unit) by Type (2020-2025)
Table 32. Global Short Bowel Syndrome Drugs Sales (K Units) by Application
Table 33. Global Short Bowel Syndrome Drugs Market Size by Application
Table 34. Global Short Bowel Syndrome Drugs Sales by Application (2020-2025) & (K Units)
Table 35. Global Short Bowel Syndrome Drugs Sales Market Share by Application (2020-2025)
Table 36. Global Short Bowel Syndrome Drugs Market Size by Application (2020-2025) & (M USD)
Table 37. Global Short Bowel Syndrome Drugs Market Share by Application (2020-2025)
Table 38. Global Short Bowel Syndrome Drugs Sales Growth Rate by Application (2020-2025)
Table 39. Global Short Bowel Syndrome Drugs Sales by Region (2020-2025) & (K Units)
Table 40. Global Short Bowel Syndrome Drugs Sales Market Share by Region (2020-2025)
Table 41. Global Short Bowel Syndrome Drugs Market Size by Region (2020-2025) & (M USD)
Table 42. Global Short Bowel Syndrome Drugs Market Size Market Share by Region (2020-2025)
Table 43. North America Short Bowel Syndrome Drugs Sales by Country (2020-2025) & (K Units)
Table 44. North America Short Bowel Syndrome Drugs Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Short Bowel Syndrome Drugs Sales by Country (2020-2025) & (K Units)
Table 46. Europe Short Bowel Syndrome Drugs Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Short Bowel Syndrome Drugs Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Short Bowel Syndrome Drugs Market Size by Region (2020-2025) & (M USD)
Table 49. South America Short Bowel Syndrome Drugs Sales by Country (2020-2025) & (K Units)
Table 50. South America Short Bowel Syndrome Drugs Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Short Bowel Syndrome Drugs Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Short Bowel Syndrome Drugs Market Size by Region (2020-2025) & (M USD)
Table 53. Global Short Bowel Syndrome Drugs Production (K Units) by Region(2020-2025)
Table 54. Global Short Bowel Syndrome Drugs Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Short Bowel Syndrome Drugs Revenue Market Share by Region (2020-2025)
Table 56. Global Short Bowel Syndrome Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Short Bowel Syndrome Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Short Bowel Syndrome Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Short Bowel Syndrome Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Short Bowel Syndrome Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Emmaus Medical Basic Information
Table 62. Emmaus Medical Short Bowel Syndrome Drugs Product Overview
Table 63. Emmaus Medical Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Emmaus Medical Business Overview
Table 65. Emmaus Medical SWOT Analysis
Table 66. Emmaus Medical Recent Developments
Table 67. Merck Basic Information
Table 68. Merck Short Bowel Syndrome Drugs Product Overview
Table 69. Merck Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Merck Business Overview
Table 71. Merck SWOT Analysis
Table 72. Merck Recent Developments
Table 73. Takeda Basic Information
Table 74. Takeda Short Bowel Syndrome Drugs Product Overview
Table 75. Takeda Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Takeda Business Overview
Table 77. Takeda SWOT Analysis
Table 78. Takeda Recent Developments
Table 79. Ardelyx Basic Information
Table 80. Ardelyx Short Bowel Syndrome Drugs Product Overview
Table 81. Ardelyx Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Ardelyx Business Overview
Table 83. Ardelyx Recent Developments
Table 84. Naia Pharmaceuticals Basic Information
Table 85. Naia Pharmaceuticals Short Bowel Syndrome Drugs Product Overview
Table 86. Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Naia Pharmaceuticals Business Overview
Table 88. Naia Pharmaceuticals Recent Developments
Table 89. Nutrinia Basic Information
Table 90. Nutrinia Short Bowel Syndrome Drugs Product Overview
Table 91. Nutrinia Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Nutrinia Business Overview
Table 93. Nutrinia Recent Developments
Table 94. OxThera Basic Information
Table 95. OxThera Short Bowel Syndrome Drugs Product Overview
Table 96. OxThera Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. OxThera Business Overview
Table 98. OxThera Recent Developments
Table 99. GLyPharma Therapeutic Basic Information
Table 100. GLyPharma Therapeutic Short Bowel Syndrome Drugs Product Overview
Table 101. GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. GLyPharma Therapeutic Business Overview
Table 103. GLyPharma Therapeutic Recent Developments
Table 104. Sancilio Pharmaceuticals Basic Information
Table 105. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Product Overview
Table 106. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Sancilio Pharmaceuticals Business Overview
Table 108. Sancilio Pharmaceuticals Recent Developments
Table 109. Zealand Pharma Basic Information
Table 110. Zealand Pharma Short Bowel Syndrome Drugs Product Overview
Table 111. Zealand Pharma Short Bowel Syndrome Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Zealand Pharma Business Overview
Table 113. Zealand Pharma Recent Developments
Table 114. Global Short Bowel Syndrome Drugs Sales Forecast by Region (2026-2033) & (K Units)
Table 115. Global Short Bowel Syndrome Drugs Market Size Forecast by Region (2026-2033) & (M USD)
Table 116. North America Short Bowel Syndrome Drugs Sales Forecast by Country (2026-2033) & (K Units)
Table 117. North America Short Bowel Syndrome Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 118. Europe Short Bowel Syndrome Drugs Sales Forecast by Country (2026-2033) & (K Units)
Table 119. Europe Short Bowel Syndrome Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 120. Asia Pacific Short Bowel Syndrome Drugs Sales Forecast by Region (2026-2033) & (K Units)
Table 121. Asia Pacific Short Bowel Syndrome Drugs Market Size Forecast by Region (2026-2033) & (M USD)
Table 122. South America Short Bowel Syndrome Drugs Sales Forecast by Country (2026-2033) & (K Units)
Table 123. South America Short Bowel Syndrome Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Middle East and Africa Short Bowel Syndrome Drugs Sales Forecast by Country (2026-2033) & (Units)
Table 125. Middle East and Africa Short Bowel Syndrome Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 126. Global Short Bowel Syndrome Drugs Sales Forecast by Type (2026-2033) & (K Units)
Table 127. Global Short Bowel Syndrome Drugs Market Size Forecast by Type (2026-2033) & (M USD)
Table 128. Global Short Bowel Syndrome Drugs Price Forecast by Type (2026-2033) & (USD/Unit)
Table 129. Global Short Bowel Syndrome Drugs Sales (K Units) Forecast by Application (2026-2033)
Table 130. Global Short Bowel Syndrome Drugs Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Short Bowel Syndrome Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Short Bowel Syndrome Drugs Market Size (M USD), 2024-2033
Figure 5. Global Short Bowel Syndrome Drugs Market Size (M USD) (2020-2033)
Figure 6. Global Short Bowel Syndrome Drugs Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Short Bowel Syndrome Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Short Bowel Syndrome Drugs Product Life Cycle
Figure 13. Short Bowel Syndrome Drugs Sales Share by Manufacturers in 2024
Figure 14. Global Short Bowel Syndrome Drugs Revenue Share by Manufacturers in 2024
Figure 15. Short Bowel Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Short Bowel Syndrome Drugs Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Short Bowel Syndrome Drugs Revenue in 2024
Figure 18. Industry Chain Map of Short Bowel Syndrome Drugs
Figure 19. Global Short Bowel Syndrome Drugs Market PEST Analysis
Figure 20. Global Short Bowel Syndrome Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Short Bowel Syndrome Drugs Market Share by Type
Figure 27. Sales Market Share of Short Bowel Syndrome Drugs by Type (2020-2025)
Figure 28. Sales Market Share of Short Bowel Syndrome Drugs by Type in 2024
Figure 29. Market Size Share of Short Bowel Syndrome Drugs by Type (2020-2025)
Figure 30. Market Size Share of Short Bowel Syndrome Drugs by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Short Bowel Syndrome Drugs Market Share by Application
Figure 33. Global Short Bowel Syndrome Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global Short Bowel Syndrome Drugs Sales Market Share by Application in 2024
Figure 35. Global Short Bowel Syndrome Drugs Market Share by Application (2020-2025)
Figure 36. Global Short Bowel Syndrome Drugs Market Share by Application in 2024
Figure 37. Global Short Bowel Syndrome Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global Short Bowel Syndrome Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global Short Bowel Syndrome Drugs Market Size Market Share by Region (2020-2025)
Figure 40. North America Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Short Bowel Syndrome Drugs Sales Market Share by Country in 2024
Figure 43. North America Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Short Bowel Syndrome Drugs Market Size Market Share by Country in 2024
Figure 45. U.S. Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Short Bowel Syndrome Drugs Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Short Bowel Syndrome Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Short Bowel Syndrome Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Short Bowel Syndrome Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Short Bowel Syndrome Drugs Sales Market Share by Country in 2024
Figure 53. Europe Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Short Bowel Syndrome Drugs Market Size Market Share by Country in 2024
Figure 55. Germany Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Short Bowel Syndrome Drugs Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Short Bowel Syndrome Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific Short Bowel Syndrome Drugs Market Size Market Share by Region in 2024
Figure 68. China Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Short Bowel Syndrome Drugs Sales and Growth Rate (K Units)
Figure 79. South America Short Bowel Syndrome Drugs Sales Market Share by Country in 2024
Figure 80. South America Short Bowel Syndrome Drugs Market Size and Growth Rate (M USD)
Figure 81. South America Short Bowel Syndrome Drugs Market Size Market Share by Country in 2024
Figure 82. Brazil Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Short Bowel Syndrome Drugs Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Short Bowel Syndrome Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Short Bowel Syndrome Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Short Bowel Syndrome Drugs Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Short Bowel Syndrome Drugs Production Market Share by Region (2020-2025)
Figure 103. North America Short Bowel Syndrome Drugs Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Short Bowel Syndrome Drugs Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Short Bowel Syndrome Drugs Production (K Units) Growth Rate (2020-2025)
Figure 106. China Short Bowel Syndrome Drugs Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Short Bowel Syndrome Drugs Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Short Bowel Syndrome Drugs Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Short Bowel Syndrome Drugs Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Short Bowel Syndrome Drugs Market Share Forecast by Type (2026-2033)
Figure 111. Global Short Bowel Syndrome Drugs Sales Forecast by Application (2026-2033)
Figure 112. Global Short Bowel Syndrome Drugs Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Short Bowel Syndrome Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Short Bowel Syndrome Drugs Market Size (M USD), 2024-2033
Figure 5. Global Short Bowel Syndrome Drugs Market Size (M USD) (2020-2033)
Figure 6. Global Short Bowel Syndrome Drugs Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Short Bowel Syndrome Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Short Bowel Syndrome Drugs Product Life Cycle
Figure 13. Short Bowel Syndrome Drugs Sales Share by Manufacturers in 2024
Figure 14. Global Short Bowel Syndrome Drugs Revenue Share by Manufacturers in 2024
Figure 15. Short Bowel Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Short Bowel Syndrome Drugs Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Short Bowel Syndrome Drugs Revenue in 2024
Figure 18. Industry Chain Map of Short Bowel Syndrome Drugs
Figure 19. Global Short Bowel Syndrome Drugs Market PEST Analysis
Figure 20. Global Short Bowel Syndrome Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Short Bowel Syndrome Drugs Market Share by Type
Figure 27. Sales Market Share of Short Bowel Syndrome Drugs by Type (2020-2025)
Figure 28. Sales Market Share of Short Bowel Syndrome Drugs by Type in 2024
Figure 29. Market Size Share of Short Bowel Syndrome Drugs by Type (2020-2025)
Figure 30. Market Size Share of Short Bowel Syndrome Drugs by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Short Bowel Syndrome Drugs Market Share by Application
Figure 33. Global Short Bowel Syndrome Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global Short Bowel Syndrome Drugs Sales Market Share by Application in 2024
Figure 35. Global Short Bowel Syndrome Drugs Market Share by Application (2020-2025)
Figure 36. Global Short Bowel Syndrome Drugs Market Share by Application in 2024
Figure 37. Global Short Bowel Syndrome Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global Short Bowel Syndrome Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global Short Bowel Syndrome Drugs Market Size Market Share by Region (2020-2025)
Figure 40. North America Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Short Bowel Syndrome Drugs Sales Market Share by Country in 2024
Figure 43. North America Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Short Bowel Syndrome Drugs Market Size Market Share by Country in 2024
Figure 45. U.S. Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Short Bowel Syndrome Drugs Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Short Bowel Syndrome Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Short Bowel Syndrome Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Short Bowel Syndrome Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Short Bowel Syndrome Drugs Sales Market Share by Country in 2024
Figure 53. Europe Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Short Bowel Syndrome Drugs Market Size Market Share by Country in 2024
Figure 55. Germany Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Short Bowel Syndrome Drugs Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Short Bowel Syndrome Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific Short Bowel Syndrome Drugs Market Size Market Share by Region in 2024
Figure 68. China Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Short Bowel Syndrome Drugs Sales and Growth Rate (K Units)
Figure 79. South America Short Bowel Syndrome Drugs Sales Market Share by Country in 2024
Figure 80. South America Short Bowel Syndrome Drugs Market Size and Growth Rate (M USD)
Figure 81. South America Short Bowel Syndrome Drugs Market Size Market Share by Country in 2024
Figure 82. Brazil Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Short Bowel Syndrome Drugs Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Short Bowel Syndrome Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Short Bowel Syndrome Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Short Bowel Syndrome Drugs Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Short Bowel Syndrome Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Short Bowel Syndrome Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Short Bowel Syndrome Drugs Production Market Share by Region (2020-2025)
Figure 103. North America Short Bowel Syndrome Drugs Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Short Bowel Syndrome Drugs Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Short Bowel Syndrome Drugs Production (K Units) Growth Rate (2020-2025)
Figure 106. China Short Bowel Syndrome Drugs Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Short Bowel Syndrome Drugs Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Short Bowel Syndrome Drugs Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Short Bowel Syndrome Drugs Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Short Bowel Syndrome Drugs Market Share Forecast by Type (2026-2033)
Figure 111. Global Short Bowel Syndrome Drugs Sales Forecast by Application (2026-2033)
Figure 112. Global Short Bowel Syndrome Drugs Market Share Forecast by Application (2026-2033)
